Similar articles

• [The hematopoietic system in patients with congenital cyanotic heart disease].

  Pellar J. Pellar J. Wiad Lek. 1968 Oct 15;21(20):1811-4. Wiad Lek. 1968. PMID: 4883228 Review. Polish. No abstract available.
• Whole blood coagulation measured by modified thrombelastography (ROTEM) is impaired in infants with congenital heart diseases.

  Osthaus WA, Boethig D, Johanning K, Rahe-Meyer N, Theilmeier G, Breymann T, Suempelmann R. Osthaus WA, et al. Blood Coagul Fibrinolysis. 2008 Apr;19(3):220-5. doi: 10.1097/MBC.0b013e3282f54532. Blood Coagul Fibrinolysis. 2008. PMID: 18388502
• Cyanotic congenital heart disease in children: hemostatic disorders and relevance of molecular markers of hemostasis.

  Suarez CR, Menendez CE, Griffin AJ, Ow EP, Walenga JM, Fareed J. Suarez CR, et al. Semin Thromb Hemost. 1984 Oct;10(4):285-9. doi: 10.1055/s-2007-1004434. Semin Thromb Hemost. 1984. PMID: 6515422 No abstract available.
• [Study of coagulation factors in cyanotic children with congenital heart defects].

  Goldschmidt B. Goldschmidt B. Ann Paediatr. 1966;207(5):321-8. Ann Paediatr. 1966. PMID: 6012677 German. No abstract available.
• Haematological considerations in patients with cyanotic congenital heart disease: a review.

  Auluck A, Manohar C. Auluck A, et al. Dent Update. 2006 Dec;33(10):617-8, 620-2. doi: 10.12968/denu.2006.33.10.617. Dent Update. 2006. PMID: 17209537 Review.